Urol. praxi. 2026;27(3):159-164 | DOI: 10.36290/uro.2025.079

Application of molecular diagnostic methods in the detection of urological and sexually transmitted infections

RNDr. Kateřina Černá, Ph.D.1, 2, RNDr. Jana Martínková Němcová, Ph.D.1, 2, RNDr. Radek Šíma, Ph.D.1, 2
1 Bioptická laboratoř, s. r. o., Plzeň
2 Šiklův ústav patologie, Lékařská fakulta UK v Plzni a Fakultní nemocnice Plzeň

Urinary tract infections represent a significant health concern requiring rapid and accurate diagnostics. Traditional methods, particularly culture, remain the gold standard but have limitations in slower turnaround times and reduced sensitivity. Molecular biology techniques offer higher specificity, sensitivity, and the ability to detect non-cultivable or fastidious pathogens. They are increasingly applied not only in diagnosing common and complicated infections but also in monitoring high-risk patients, such as kidney transplant recipients. This article summarizes the principles, indications, and clinical applications of these methods, highlighting their role in the modern diagnosis of urinary tract infections.

Keywords: urinary tract infections, molecular diagnostics, PCR, next-generation sequencing, kidney transplantation, pathogen detection.

Received: September 9, 2025; Revised: October 1, 2025; Accepted: October 23, 2025; Prepublished online: October 23, 2025; Published: October 21, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černá K, Martínková Němcová J, Šíma R. Application of molecular diagnostic methods in the detection of urological and sexually transmitted infections. Urol. praxi. 2026;27(3):159-164. doi: 10.36290/uro.2025.079.
Download citation

References

  1. Yang X, Chen H, Zheng Y, et al. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front Public Health. 2022;10:888205. Go to original source...
  2. Isenberg HD. Clinical microbiology: Past, present, and future. J Clin Microbiol 2003;41(3):917-918. Go to original source...
  3. Sravanthi K, Sattiraju KS, Paul S, et al. Robert Koch: From Anthrax to Tuberculosis - A Journey in Medical Science. Cureus. 2024;16(11):e72955. Go to original source...
  4. Mullis K, Faloona F, Scharf S, et al. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. Cold Spring Harb Symp Quant Biol 1986;51:263-273. Go to original source...
  5. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350-1354. Go to original source...
  6. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-5467. Go to original source...
  7. Wang QY, Zheng LQ, Li RH, et al. Clinician-collected urethra swab: A good alternative sample type using cobas 4800 system for Chlamydia trachomatis and Neisseria gonorrhoeae in men. J Clin Lab Anal. 2020;34(9):e23331. Go to original source...
  8. Rodrigues R, Vieira-Baptista P, Catalão C, et al. Chlamydial and Gonococcal Genital Infections: A Narrative Review. J Pers Med 2023;13(7):1170. Go to original source...
  9. Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat Rev Microbiol. 2018;16(4):226-240. Go to original source...
  10. Grygiel-Górniak B, Folga BA. Chlamydia trachomatis -An Emerging Old Entity? Microorganisms. 2023;11(5):1283. Go to original source...
  11. Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis. 2015;15:307. Go to original source...
  12. Combaz N, Kuhn A. A Systematic Review of Mycoplasma and Ureaplasma in Urogynaecology. Geburtshilfe Frauenheilkd. 2017;77(12):1299-1303. Go to original source...
  13. Catlin BW. Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev. 1992;5(3):213-237. Go to original source...
  14. Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577): 1961-1971. Go to original source...
  15. Johnston C, Corey L. Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding. Clin Microbiol Rev. 2015;29(1):149-161. Go to original source...
  16. Singh AE, Romanowski B. Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features. Clin Microbiol Rev. 1999;12(2):187-209. Go to original source...
  17. Meza-Romero R, Navarrete-Dechent C, Downey C. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment. Clin Cosmet Investig Dermatol. 2019;12:373-381. Go to original source...
  18. De Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology. 2004;324(1):17-27. Go to original source...
  19. Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res. 2017;231:119-127. Go to original source...
  20. Silva SJR da, Kohl A, Pena L, et al. Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions. IScience. 2023;26(6):106759. Go to original source...
  21. Mindlova M, Boucek P, Saudek F, et al. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center. Clin Transplant. 2012;26(2):267-274. Go to original source...
  22. Thomas M, Russ G, Mathew T, et al. Four cases of CMV ureteritis: Emergence of a new pattern of disease? Clin Transplant. 2001;15(5):354-358. Go to original source...
  23. Bae SH, Chung BH, Park YK, et al. Cytomegalovirus Induced Interstitial Nephritis and Ureteral Stenosis in Renal Transplant Recipient. Korean J Intern Med. 2012;27(4):470-473. Go to original source...
  24. Padayachee WPR, Sadhwani S, Doherty SW, et al. Haemorrhagic cystitis due to cytomegalovirus in a patient with AIDS. Afr J Urol. 2020;26(30):1-6. Go to original source...
  25. Ersan S, Yorukoglu K, Sert M, et al. Unusual Case of Severe Late-Onset Cytomegalovirus-Induced Hemorrhagic Cystitis and Ureteritis in a Renal Transplant Patient. Ren Fail. 2012;34(2):247-250. Go to original source...
  26. Torii Y, Morioka I, Kakei Y, et al. Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment. BMC Infect Dis. 2023;23(1):1-7. Go to original source...
  27. Park JE, Kim JY, Yun SA, et al. Performance evaluation of the Real-Q cytomegalovirus (CMV) quantification kit using two real-time PCR systems for quantifying CMV DNA in whole blood. Ann Lab Med. 2016;36(6):603-606. Go to original source...
  28. Boutolleau D, L'Honneur AS, Germi R, et al. Inter-laboratory variability in cytomegalovirus DNA quantification: implications for standardization and clinical monitoring. J Clin Microbiol. 2025;63(7):e0191124. Go to original source...
  29. Preiksaitis JK, Hayden RT, Tong Y, et al. Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples. Clinical Infectious Diseases. 2016;63(5):583-589. Go to original source...
  30. Göhring K, Hamprecht K, Jahn G. Antiviral Drug- and Multi­drug Resistance in Cytomegalovirus Infected SCT Patients. Comput Struct Biotechnol J. 2015;13:153-158. Go to original source...
  31. Streck NT, Espy MJ, Ferber MJ, et al. Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus. J Clin Microbiol. 2023;61(10):e0042923. Go to original source...
  32. World Health Organization. Report on global sexually transmitted infection surveillance 2018 [Internet]. Geneva: WHO; 2018 [cited 2025 Aug 26]. Available from: https://www.who.int/publications/i/item/9789241565691.
  33. Hufstetler K, Llata E, Miele K, et al. Clinical Updates in Sexually Transmitted Infections, 2024. J Womens Health. 2024;33(6):827-837. Go to original source...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.